Growing, ageing and migrating
populations, increasingly empowered patients and mounting funding pressures are all having a dramatic
impact on healthcare. Our strategy is to develop innovative products and services that address unmet
medical needs and are of real value to society. This will ensure we remain an industry leader in the
face of changing healthcare trends.
Our innovative, market-leading pharmaceuticals
and diagnostics businesses are united by a single mission: creating sustainable value through products
and services that save or at least significantly enhance people’s lives by helping to detect, correctly
diagnose and appropriately treat disease. Further details can be found under Our
Company .
The result is a focus on long-term success rather
than short-term gain. As our products take between eight and 12 years to bring to market, protecting
the current and future value of our company is critical. We believe this creates a strong business
case
for sustainability .
The three elements of
sustainability – society, environment and economy – are interdependent. We will not be successful in
the long term without meeting our environmental and social responsibilities, and equally we cannot contribute
to society and environmental protection without economic success. We try to balance these three elements
in all aspects of managing our business .
- Managing
our business responsibly, with high levels of corporate governance
- Growing
our business sustainably and creating high-quality, rewarding employment
- Ensuring
access to our products for those who need them
- Valuing our employees
and protecting their safety
- Reducing the environmental impacts
and costs of both our products and our operations
- Supporting communities
through local initiatives and by encouraging innovation in science and the arts.
Our
products and services not only save lives and ease
suffering, they also create economic value. The right medication, received in time and at the right
dose, hastens recovery and alleviates the most serious – and costly – effects of a disease. This can
shorten or even avoid hospital stays. Patients can return to work sooner and reduce earnings lost through
illness. We believe these overall social and economic benefits provide value
beyond
just the product
itself.
Ultimately patients and society
only benefit
from products if there is access to them. Therefore we are working with local and international partners
to improve healthcare delivery e.g. through health awareness programmes, better preventive health
services and increased access to medicines. We support projects where we can contribute
skills and know-how
as we believe this is a more sustainable solution.
Our
sustainability commitments ensure we remain a responsible company that inspires
pride in its employees and deserves the trust of all its stakeholders.
Read
more about the principles that guide our company in our Corporate Principles and Code
of Conduct. |
 |